22例家族聚集性青年缺血性卒中患者的全外显子组测序
该研究对22例来自多发性卒中家系、首次缺血性卒中年龄<56岁的先证者进行全外显子组测序,并使用综合卒中基因panel搜索卒中相关基因变异。6/22例先证者携带与卒中亚型相关的致病或可能致病性变异,但多数家族聚集性卒中患者未发现明确遗传病因。
要点
- 全外显子组测序联合综合卒中基因panel可识别罕见单基因卒中形式。
- 6/22例先证者携带与卒中亚型相关的致病或可能致病性变异。
- 多数家族聚集性卒中患者缺乏可识别的遗传病因,需谨慎评估变异致病性。
核心结论
- 全外显子组测序联合综合卒中基因panel可能识别罕见单基因卒中形式,但需仔细评估临床特征和新变异的潜在致病性。
- 本研究中多数家族聚集性卒中个体缺乏任何可识别的遗传病因。
研究设计与样本
- 对22例来自多发性卒中家系、首次缺血性卒中年龄<56岁的先证者进行全外显子组测序。
- 使用综合卒中基因panel搜索卒中相关基因变异,并将先证者临床卒中亚型与既往报道的致病性变异相关临床特征关联。
- 对7个家系的亲属进行基因分型以评估意义未明的卒中基因变异。
- 对2个不明来源栓塞性卒中的大家系额外成员进行全外显子组测序以探索发现新卒中基因的可能性。
主要发现
- 22例先证者中6例携带与所报道卒中亚型相关的致病或可能致病性变异。
- 识别到NOTCH3已知致病性变异和ACAD9基因可能致病性变异。
- 在不明确来源栓塞性卒中且促血栓状态的先证者中发现新JAK2:c.3188G>A (p.Arg1063His)突变,但该家系外显不全。
- 2例先证者检测到COL4A2:c.3368A>G (p.Glu1123Gly),但在其家系中未与疾病共分离。
- 对2个不明来源栓塞性卒中家系多名成员的全外显子组测序发现既往未与卒中关联的基因中可能致病性变异:GPR142:c.148C>G (p.Leu50Val)和PTPRN2:c.2416A>G (p.Ile806Val);LRRC1 c.808A>G (p.Ile270Val)、SLC7A10 c.1294dupG (p.Val432fs)、IKBKB:c.1070C>T (p.Ala357Val)和OXGR1 c.392G>A (p.Arg131His)。
临床怎么用
- 对家族聚集性青年缺血性卒中患者可考虑全外显子组测序联合综合卒中基因panel进行遗传筛查。
- 对检出的新变异需结合临床特征和家系共分离情况谨慎评估致病性,避免过度解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Backgrounds and Purpose- Although new methods for genetic analyses are rapidly evolving, there are currently knowledge gaps in how to detect Mendelian forms of stroke. Methods- We performed whole-exome sequencing in 22 probands, under 56 years at their first ischemic stroke episode, from multi-incident stroke families. With the use of a comprehensive stroke-gene panel, we searched for variants in stroke-related genes. The probands' clinical stroke subtype was related to clinical characteristics previously associated with pathogenic variants in these genes. Relatives were genotyped in 7 families to evaluate stroke-gene variants of unknown significance. In 2 larger families with embolic stroke of unknown source, whole-exome sequencing was performed in additional members to examine the possibility of identifying new stroke genes. Results- Six of 22 probands carried pathogenic or possibly pathogenic variants in genes reported to be associated with their stroke subtype. A known pathogenic variant in NOTCH3 and a possibly pathogenic variant in ACAD9 gene were identified. A novel JAK2:c.3188G>A (p.Arg1063His) mutation was seen in a proband with embolic stroke of undetermined source and prothrombotic status. However, penetrance in the family was incomplete. COL4A2:c.3368A>G (p.Glu1123Gly) was detected in 2 probands but did not cosegregate with the disease in their families. Whole-exome sequencing in multiple members of 2 pedigrees with embolic stroke of undetermined source revealed possibly pathogenic variants in genes not previously associated with stroke, GPR142:c.148C>G (p.Leu50Val), and PTPRN2:c.2416A>G (p.Ile806Val); LRRC1 c.808A>G (p.Ile270Val), SLC7A10c.1294dupG (p.Val432fs), IKBKB: c.1070C>T (p.Ala357Val), and OXGR1 c.392G>A (p.Arg131His), respectively. Conclusions- Screening with whole-exome sequencing using a comprehensive stroke-gene panel may identify rare monogenic forms of stroke, but careful evaluation of clinical characteristics and potential pathogenicity of novel variants remain important. In our study, the majority of individuals with familial aggregation of stroke lacked any identified genetic causes.
引用
- Ilinca A, Martinez-Majander N, Samuelsson S, et al. Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of Stroke. Stroke. 2020. PMID: 32172663. doi:10.1161/STROKEAHA.119.027474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。